Elite Pharmaceuticals, Inc. Foreign Income Tax Expense (Benefit), Continuing Operations
Elite Pharmaceuticals, Inc. (ELTP) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $1.87 million for the 12-month period ending 2017-03-31, per its 10-K filed 2017-06-14.
Discontinued › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2017-06-14
- Elite Pharmaceuticals, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2017 was $1.87M, a 256.55% increase from fiscal 2016.
- Elite Pharmaceuticals, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2016 was $524.50K.
- Elite Pharmaceuticals, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Elite Pharmaceuticals, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2014 was $295.71M.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|
| 2017-03-31 | $1.87M 10-K · filed 2017-06-14 | |
| 2016-03-31 | $524.50K 10-K · filed 2017-06-14 | $524.50M 10-K · filed 2016-06-15 |
| 2015-03-31 | $0.00 10-K · filed 2017-06-14 | |
| 2014-03-31 | $295.71M 10-K · filed 2016-06-15 | -$295.71K 10-K · filed 2014-06-30 |
| 2013-03-31 | -$359.82K 10-K · filed 2014-06-30 | $359.82K 10-K · filed 2013-06-21 |
| 2012-03-31 | $486.80K 10-K · filed 2013-06-21 |